Abstract
Two vectors, pWAI80 and pROH80, for expression of single-chain Fv fragments (ScFv) were constructed. The anti-CD3 VH and VL genes were amplified from UCHT1 cells by RT-PCR and sequenced. Both genes were cloned in pWAI80 to express native ScFv and pROH80 for GST-ScFv fusion protein expression. The expression products were analysed by ELISA and Western blot. The combining site of OKT3 was modeled. Human Ig LS1 and Nd were selected as acceptors of CDRs of OKT3 VL and VH to construct a reshaping antibody against CD3. By comparing OKT3, LS1 and Nd with their own family sequences, some residues were changed and the reshaping VL and VH genes were designed. The full VH gene was assembled in three steps with eight chemically synthesized oligonucleotide fragments using overlapping PCR and sequenced. The VH gene was expressed as active protein in pCOMB3 and as inclusion bodies in pGEX-4T-1 by ELISA and Western blot analysis.
Similar content being viewed by others
References
Sarah, B., Edward, R., Irene, L.et al., The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retainin vitro immunosuppressive properties,Eur. J. Immunol., 1993, 23:403.
Morrison, S.L., Johnson, M.J., Herzenberg, L. A.et al., Chimeric human antibodies-mouse antigen binding domains with human constant regions,PNAS, 1984, 81:6851.
Riechmann, L. M., Clark, H.W.et al., Reshaping human antibodies for therapy,Nature, 1988, 332:323.
Arne, S., Ilse, P., Andreas, P.et al., The functional expression of antibody Fv fragments inEscherichia: improved vectors and a general applicable purification technique,Bio / Technology, 1991, 9:273.
Carlos, F. B, Dennis, R. B.,Cold Spring Harbour Laboratory Course on Monoclonal Antibodies From Combinatorial Libraries, the Scripps Research Institute, 1993.
Borrebaeck, C.A.K.,Antibody Engineering, A Practical Guide, New York:W.H. Freeman and Company, 1992, 131.
Phlipp, H., Terence, P., Grey, W., “Diabodies”: small bivalent and bispecific antibody fragments,PNAS, 1993, 90:6444.
Adair, A.R., Engineering antibodies for therapy,Immunological Reviews, 1992, 130:14.
Woodle, E. S., Thistlethwaitee, J. R., Jolliffe, L. K.et al., Humanized OKT3 antibodies successful transfer or immune modulating properties and idiotype expression,J. Immunol., 1992, 148:2756.
Author information
Authors and Affiliations
Additional information
Project supported by the National Natural Science Foundation of China and “863” Plan.
Rights and permissions
About this article
Cite this article
Liu, X., Xiao, S., Gu, Z. et al. Construction of expression vectors and study on single-chain antibody and reshaping single-domain antibody against CD3. Sci. China Ser. C.-Life Sci. 40, 270–276 (1997). https://doi.org/10.1007/BF02879087
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02879087